Client News

AFYREN confirms drawdown of €7 million in previously secured financing for its subsidiary AFYREN NEOXY

Abivax Provides 2026 Corporate Outlook

Andera Partners Leads $67 Million Series A Financing in Spiro Medical to Develop a Neuromodulation System for Asthma

AL-S Pharma to present at the upcoming J. P. Morgan 2026 Annual Healthcare Conference on Thursday, January 15

EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan

Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent

Mainz Biomed Provides Review of 2025 Highlights

InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum

FDA approves another interchangeable Ranibizumab Biosimilar, Nufymco® – Strengthening US Presence with Zydus as Commercialization Partner

Abivax to be Added to Nasdaq Biotechnology Index